The antigen-presenting cells (APCs), primarily dendritic cells (DCs) and macrophages, can prime specific CD4+ and CD8+ T-lymphocyte-mediated responses to cancer cells, thanks to their ability to recognize tumor-associated or specific antigens, and present antigen-derived peptides in the MHC class II. Here, CD4 is linked to cancer.